Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: A Southwest Oncology Group study.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 4, p. 335, doi. 10.1007/s10637-005-4345-3
- By:
- Publication type:
- Article
Works matching IS 01676997 AND DT 2006 AND VI 24 AND IP 4
Results: 13
1
2
A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 4, p. 327, doi. 10.1007/s10637-006-5392-0
- By:
- Publication type:
- Article
3
The Wnt-dependent signaling pathways as target in oncology drug discovery.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 4, p. 263, doi. 10.1007/s10637-005-5199-4
- By:
- Publication type:
- Article
4
Phase I trial of thalidomide and Interleukin-2 in patients with metastatic renal cell carcinoma.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 4, p. 321, doi. 10.1007/s10637-005-5211-z
- By:
- Publication type:
- Article
5
A phase I Study with oral SU5416 in patients with advanced solid tumors: A drug inducing its clearance.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 4, p. 299, doi. 10.1007/s10637-005-4061-z
- By:
- Publication type:
- Article
6
Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells: in vitro and in cancer patients.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 4, p. 291, doi. 10.1007/s10637-006-5269-2
- By:
- Publication type:
- Article
7
A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 4, p. 311, doi. 10.1007/s10637-005-5055-6
- By:
- Publication type:
- Article
8
A phase II study of chloroquinoxaline sulfonamide (CQS) in patients with metastatic colorectal carcinoma (MCRC).
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 4, p. 343, doi. 10.1007/s10637-005-4827-3
- By:
- Publication type:
- Article
9
Population pharmacokinetics and bioavailability of motexafin gadolinium (Xcytrin<sup>®</sup>) in CD1 mice following intravenous and intraperitoneal injection.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 4, p. 281, doi. 10.1007/s10637-006-5383-1
- By:
- Publication type:
- Article
10
Phase II study of rubitecan, an oral camptothecin in patients with advanced colorectal cancer who have failed previous 5-fluorouracil based chemotherapy.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 4, p. 359, doi. 10.1007/s10637-006-6451-2
- By:
- Publication type:
- Article
11
A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 4, p. 353, doi. 10.1007/s10637-006-6452-1
- By:
- Publication type:
- Article
12
A phase I study of flavopiridol and docetaxel.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 4, p. 305, doi. 10.1007/s10637-005-4343-5
- By:
- Publication type:
- Article
13
SarCNU in recurrent or metastatic colorectal cancer: A phase II study of the National Cancer Institute of Canada Clinical Trials Group.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 4, p. 347, doi. 10.1007/s10637-006-5730-2
- By:
- Publication type:
- Article